Logo image of ACO-Y.CA

ATCO LTD -CL 'II' (ACO-Y.CA) Stock Fundamental Analysis

Canada - Toronto Stock Exchange - TSX:ACO-Y - CA0467895094 - Common Stock

60 CAD
-0.52 (-0.86%)
Last: 12/12/2025, 7:00:00 PM
Fundamental Rating

4

ACO-Y gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 19 industry peers in the Multi-Utilities industry. ACO-Y has only an average score on both its financial health and profitability. ACO-Y has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • ACO-Y had positive earnings in the past year.
  • ACO-Y had a positive operating cash flow in the past year.
  • In the past 5 years ACO-Y has always been profitable.
  • In the past 5 years ACO-Y always reported a positive cash flow from operatings.
ACO-Y.CA Yearly Net Income VS EBIT VS OCF VS FCFACO-Y.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 1.55%, ACO-Y is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • ACO-Y has a Return On Equity of 9.08%. This is amongst the best in the industry. ACO-Y outperforms 85.71% of its industry peers.
  • ACO-Y's Return On Invested Capital of 3.73% is on the low side compared to the rest of the industry. ACO-Y is outperformed by 76.19% of its industry peers.
  • ACO-Y had an Average Return On Invested Capital over the past 3 years of 3.92%. This is in line with the industry average of 3.73%.
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROIC 3.73%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ACO-Y.CA Yearly ROA, ROE, ROICACO-Y.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • ACO-Y has a Profit Margin of 8.38%. This is comparable to the rest of the industry: ACO-Y outperforms 42.86% of its industry peers.
  • ACO-Y's Profit Margin has declined in the last couple of years.
  • ACO-Y has a Operating Margin (24.56%) which is in line with its industry peers.
  • ACO-Y's Operating Margin has declined in the last couple of years.
  • Looking at the Gross Margin, with a value of 74.90%, ACO-Y is in line with its industry, outperforming 42.86% of the companies in the same industry.
  • In the last couple of years the Gross Margin of ACO-Y has remained more or less at the same level.
Industry RankSector Rank
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
ACO-Y.CA Yearly Profit, Operating, Gross MarginsACO-Y.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so ACO-Y is destroying value.
  • Compared to 1 year ago, ACO-Y has about the same amount of shares outstanding.
  • Compared to 5 years ago, ACO-Y has less shares outstanding
  • The debt/assets ratio for ACO-Y is higher compared to a year ago.
ACO-Y.CA Yearly Shares OutstandingACO-Y.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
ACO-Y.CA Yearly Total Debt VS Total AssetsACO-Y.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 5B 10B 15B 20B 25B

2.2 Solvency

  • Based on the Altman-Z score of 0.79, we must say that ACO-Y is in the distress zone and has some risk of bankruptcy.
  • ACO-Y's Altman-Z score of 0.79 is amongst the best of the industry. ACO-Y outperforms 85.71% of its industry peers.
  • ACO-Y has a debt to FCF ratio of 27.90. This is a negative value and a sign of low solvency as ACO-Y would need 27.90 years to pay back of all of its debts.
  • ACO-Y has a Debt to FCF ratio of 27.90. This is amongst the best in the industry. ACO-Y outperforms 95.24% of its industry peers.
  • A Debt/Equity ratio of 2.64 is on the high side and indicates that ACO-Y has dependencies on debt financing.
  • With a Debt to Equity ratio value of 2.64, ACO-Y is not doing good in the industry: 71.43% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Altman-Z 0.79
ROIC/WACC0.73
WACC5.13%
ACO-Y.CA Yearly LT Debt VS Equity VS FCFACO-Y.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2B 4B 6B 8B 10B

2.3 Liquidity

  • A Current Ratio of 1.81 indicates that ACO-Y should not have too much problems paying its short term obligations.
  • With an excellent Current ratio value of 1.81, ACO-Y belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
  • ACO-Y has a Quick Ratio of 1.66. This is a normal value and indicates that ACO-Y is financially healthy and should not expect problems in meeting its short term obligations.
  • With an excellent Quick ratio value of 1.66, ACO-Y belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.81
Quick Ratio 1.66
ACO-Y.CA Yearly Current Assets VS Current LiabilitesACO-Y.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

  • The Earnings Per Share has grown by an nice 10.19% over the past year.
  • ACO-Y shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.10% yearly.
  • Looking at the last year, ACO-Y shows a small growth in Revenue. The Revenue has grown by 7.75% in the last year.
  • The Revenue has been growing slightly by 0.98% on average over the past years.
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%

3.2 Future

  • The Earnings Per Share is expected to grow by 5.04% on average over the next years.
  • The Revenue is expected to grow by 0.61% on average over the next years.
EPS Next Y9.29%
EPS Next 2Y5.14%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue Next Year-5%
Revenue Next 2Y-1%
Revenue Next 3Y0.61%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ACO-Y.CA Yearly Revenue VS EstimatesACO-Y.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B 5B
ACO-Y.CA Yearly EPS VS EstimatesACO-Y.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4

4

4. Valuation

4.1 Price/Earnings Ratio

  • Based on the Price/Earnings ratio of 13.22, the valuation of ACO-Y can be described as correct.
  • ACO-Y's Price/Earnings is on the same level as the industry average.
  • Compared to an average S&P500 Price/Earnings ratio of 27.54, ACO-Y is valued rather cheaply.
  • ACO-Y is valuated correctly with a Price/Forward Earnings ratio of 12.65.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of ACO-Y is on the same level as its industry peers.
  • ACO-Y is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 24.31, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 13.22
Fwd PE 12.65
ACO-Y.CA Price Earnings VS Forward Price EarningsACO-Y.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of ACO-Y is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of ACO-Y is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 14.5
EV/EBITDA 8.55
ACO-Y.CA Per share dataACO-Y.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40

4.3 Compensation for Growth

  • ACO-Y's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.42
PEG (5Y)2.16
EPS Next 2Y5.14%
EPS Next 3Y5.04%

6

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.63%, ACO-Y has a reasonable but not impressive dividend return.
  • With a Dividend Yield of 3.63, ACO-Y pays less dividend than the industry average, which is at 5.23. 90.48% of the companies listed in the same industry pay a better dividend than ACO-Y!
  • Compared to an average S&P500 Dividend Yield of 1.92, ACO-Y pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.63%

5.2 History

  • The dividend of ACO-Y has a limited annual growth rate of 3.93%.
  • ACO-Y has been paying a dividend for at least 10 years, so it has a reliable track record.
  • ACO-Y has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)3.93%
Div Incr Years31
Div Non Decr Years34
ACO-Y.CA Yearly Dividends per shareACO-Y.CA Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 52.20% of the earnings are spent on dividend by ACO-Y. This is a bit on the high side, but may be sustainable.
  • ACO-Y's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP52.2%
EPS Next 2Y5.14%
EPS Next 3Y5.04%
ACO-Y.CA Yearly Income VS Free CF VS DividendACO-Y.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M
ACO-Y.CA Dividend Payout.ACO-Y.CA Dividend Payout, showing the Payout Ratio.ACO-Y.CA Dividend Payout.PayoutRetained Earnings

ATCO LTD -CL 'II'

TSX:ACO-Y (12/12/2025, 7:00:00 PM)

60

-0.52 (-0.86%)

Chartmill FA Rating
GICS SectorUtilities
GICS IndustryGroupUtilities
GICS IndustryMulti-Utilities
Earnings (Last)11-07
Earnings (Next)02-25
Inst Owners28.28%
Inst Owner ChangeN/A
Ins Owners0.68%
Ins Owner ChangeN/A
Market Cap6.73B
Revenue(TTM)5.14B
Net Income(TTM)431.00M
Analysts78.57
Price Target57.49 (-4.18%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.63%
Yearly Dividend1.96
Dividend Growth(5Y)3.93%
DP52.2%
Div Incr Years31
Div Non Decr Years34
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.14%
Min EPS beat(2)-3.78%
Max EPS beat(2)8.05%
EPS beat(4)3
Avg EPS beat(4)2.22%
Min EPS beat(4)-3.78%
Max EPS beat(4)8.05%
EPS beat(8)7
Avg EPS beat(8)4.37%
EPS beat(12)9
Avg EPS beat(12)2.66%
EPS beat(16)12
Avg EPS beat(16)4.06%
Revenue beat(2)0
Avg Revenue beat(2)-9.84%
Min Revenue beat(2)-17.7%
Max Revenue beat(2)-1.99%
Revenue beat(4)0
Avg Revenue beat(4)-9.73%
Min Revenue beat(4)-18.52%
Max Revenue beat(4)-0.7%
Revenue beat(8)0
Avg Revenue beat(8)-11.91%
Revenue beat(12)0
Avg Revenue beat(12)-10.29%
Revenue beat(16)1
Avg Revenue beat(16)-9.26%
PT rev (1m)0%
PT rev (3m)-1.53%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0.27%
EPS NY rev (1m)0.93%
EPS NY rev (3m)1.65%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-4.42%
Valuation
Industry RankSector Rank
PE 13.22
Fwd PE 12.65
P/S 1.31
P/FCF 14.5
P/OCF 2.76
P/B 1.42
P/tB 1.99
EV/EBITDA 8.55
EPS(TTM)4.54
EY7.57%
EPS(NY)4.74
Fwd EY7.9%
FCF(TTM)4.14
FCFY6.9%
OCF(TTM)21.76
OCFY36.26%
SpS45.88
BVpS42.35
TBVpS30.16
PEG (NY)1.42
PEG (5Y)2.16
Graham Number65.77
Profitability
Industry RankSector Rank
ROA 1.55%
ROE 9.08%
ROCE 4.79%
ROIC 3.73%
ROICexc 3.92%
ROICexgc 4.15%
OM 24.56%
PM (TTM) 8.38%
GM 74.9%
FCFM 9.02%
ROA(3y)1.62%
ROA(5y)1.41%
ROE(3y)9.17%
ROE(5y)7.94%
ROIC(3y)3.92%
ROIC(5y)3.81%
ROICexc(3y)4.06%
ROICexc(5y)3.97%
ROICexgc(3y)4.27%
ROICexgc(5y)4.16%
ROCE(3y)5.04%
ROCE(5y)4.9%
ROICexgc growth 3Y1.58%
ROICexgc growth 5Y-6.25%
ROICexc growth 3Y1.11%
ROICexc growth 5Y-6.55%
OM growth 3Y2.6%
OM growth 5Y-3.18%
PM growth 3Y14.9%
PM growth 5Y-4.41%
GM growth 3Y-0.25%
GM growth 5Y-1.16%
F-Score7
Asset Turnover0.19
Health
Industry RankSector Rank
Debt/Equity 2.64
Debt/FCF 27.9
Debt/EBITDA 5.96
Cap/Depr 234.56%
Cap/Sales 38.4%
Interest Coverage 2.33
Cash Conversion 115.87%
Profit Quality 107.66%
Current Ratio 1.81
Quick Ratio 1.66
Altman-Z 0.79
F-Score7
WACC5.13%
ROIC/WACC0.73
Cap/Depr(3y)212.07%
Cap/Depr(5y)195.52%
Cap/Sales(3y)33.77%
Cap/Sales(5y)31.75%
Profit Quality(3y)134.57%
Profit Quality(5y)187.54%
High Growth Momentum
Growth
EPS 1Y (TTM)10.19%
EPS 3Y8.59%
EPS 5Y6.1%
EPS Q2Q%13.58%
EPS Next Y9.29%
EPS Next 2Y5.14%
EPS Next 3Y5.04%
EPS Next 5YN/A
Revenue 1Y (TTM)7.75%
Revenue growth 3Y4.84%
Revenue growth 5Y0.98%
Sales Q2Q%6.09%
Revenue Next Year-5%
Revenue Next 2Y-1%
Revenue Next 3Y0.61%
Revenue Next 5YN/A
EBIT growth 1Y25.67%
EBIT growth 3Y7.57%
EBIT growth 5Y-2.22%
EBIT Next Year409.03%
EBIT Next 3Y77.89%
EBIT Next 5YN/A
FCF growth 1Y1.09%
FCF growth 3Y-8.79%
FCF growth 5Y2.94%
OCF growth 1Y16.42%
OCF growth 3Y5.63%
OCF growth 5Y7.34%

ATCO LTD -CL 'II' / ACO-Y.CA FAQ

Can you provide the ChartMill fundamental rating for ATCO LTD -CL 'II'?

ChartMill assigns a fundamental rating of 4 / 10 to ACO-Y.CA.


What is the valuation status for ACO-Y stock?

ChartMill assigns a valuation rating of 3 / 10 to ATCO LTD -CL 'II' (ACO-Y.CA). This can be considered as Overvalued.


Can you provide the profitability details for ATCO LTD -CL 'II'?

ATCO LTD -CL 'II' (ACO-Y.CA) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for ACO-Y stock?

The Price/Earnings (PE) ratio for ATCO LTD -CL 'II' (ACO-Y.CA) is 13.22 and the Price/Book (PB) ratio is 1.42.


What is the earnings growth outlook for ATCO LTD -CL 'II'?

The Earnings per Share (EPS) of ATCO LTD -CL 'II' (ACO-Y.CA) is expected to grow by 9.29% in the next year.